Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
For the success of fertilization, spindles of vertebrate oocytes must remain stable and correctly organized during the arrest in metaphase II of meiosis. Using a two-hybrid screen with
MAPK
as a bait, we have recently identified MISS (
MAPK
interacting and spindle stabilizing) which controls mouse oocyte metaphase II spindle stability. Using the same screen, we identify another
MAPK
partner,
DOC1R
(Deleted in oral cancer one related), a murine homologue of a potential human tumor suppressor gene. We characterize
DOC1R
during mouse oocyte meiosis resumption.
DOC1R
is regulated by phosphorylation during meiotic maturation by MPF (M-phase promoting factor) and by the MOS/./
MAPK
pathway.
DOC1R
and a
DOC1R
-GFP fusion localize to microtubules during meiotic maturation. Consistent with this microtubular localization, we show, by antisense and double-stranded RNA injection, that depletion of
DOC1R
induces microtubule defects in metaphase II oocytes. These defects are rescued by overexpressing a Xenopus
DOC1R
, showing that they are specific to
DOC1R
. Thus, the discovery of
DOC1R
, a substrate of
MAPK
that regulates microtubule organization of metaphase II mouse oocytes, reinforces the importance of this pathway in the control of spindle stability during the metaphase II arrest.
...
PMID:DOC1R: a MAP kinase substrate that control microtubule organization of metaphase II mouse oocytes. 1294 31